Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6381)
All Articles published online
|
Publishing Process of This Article
|
Feb 15, 2023 (publication date) through Feb 20, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Skubleny D, Lin A, Garg S, McLean R, McCall M, Ghosh S, Spratlin JL, Schiller D, Rayat G. Increased CD4/CD8 Lymphocyte ratio predicts favourable neoadjuvant treatment response in gastric cancer: A prospective pilot study. World J Gastrointest Oncol 2023; 15(2): 303-317 [PMID: 36908322 DOI: 10.4251/wjgo.v15.i2.303] |
|
|
|
| ©2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Skubleny D, Lin A, Garg S, McLean R, McCall M, Ghosh S, Spratlin JL, Schiller D, Rayat G. Increased CD4/CD8 Lymphocyte ratio predicts favourable neoadjuvant treatment response in gastric cancer: A prospective pilot study. World J Gastrointest Oncol 2023; 15(2): 303-317 [PMID: 36908322 DOI: 10.4251/wjgo.v15.i2.303] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i2/303.htm |
| Number | Citing Articles |
| 1 |
Rudresha A H, Vivek Basavaraj Maleyur, Kartik Gajanan Asutkar, Priya D, Lokesh K N, Rajeev L K, Smitha Carol Saldanha, Giri G V, Yaman Patidar, Sureshbabu M C. Clinico-pathological features and the role of CD4/CD8 lymphocyte ratio in predicting response to neoadjuvant FLOT (5-fluorouracil, leucovorin, oxaliplatin, and docetaxel) chemotherapy in locally advanced gastric cancer. Asian Journal of Oncology 2025; 11: 29 doi: 10.25259/ASJO_82_2025
|
| 2 |
Xiaoming Wang, Dayu Chen, Yuyan Ma, Dongping Mo, Feng Yan. Variation of peripheral blood-based biomarkers for response of anti-PD-1 immunotherapy in non-small-cell lung cancer. Clinical and Translational Oncology 2024; 26(8): 1934 doi: 10.1007/s12094-024-03416-5
|
| 3 |
Esraa Ali, Wenjing Ye, Sergii Pavlov, Lenka Červenková, Filip Ambrozkiewicz, Ondřej Vyčítal, Petr Hošek, Ondřej Daum, Václav Liška, Kari Hemminki, Andriy Trailin. Distribution and prognostic value of T‐cells in primary colorectal cancer and adjacent non‐tumor mucosa in stage IV versus stage I–III patients. International Journal of Cancer 2025; doi: 10.1002/ijc.70319
|
| 4 |
Chiau-Sheng Jang, I.-Chieh Chuang. CD8/CD4 ratio, CD56, and PD-L1 as prognostic markers in sinonasal mucosal melanoma. International Journal of Clinical Oncology 2026; doi: 10.1007/s10147-026-02973-9
|
| 5 |
Maodong Leng, Huiqin Jiang, Haiyan Lan, Wei Zhong, Hongna Shi, Jing Jia, Yixi Bao. Immunoregulatory function and anticancer effects of Polygonatum sibiricum polysaccharides against hepatic carcinoma via macrophage phenotype modulation. International Journal of Biological Macromolecules 2025; 319: 145423 doi: 10.1016/j.ijbiomac.2025.145423
|
| 6 |
Sibel Oyucu Orhan, Bedrettin Orhan, Yağmur Çakır, Seda Sali, Burcu Caner, Birol Ocak, Ahmet Bilgehan Şahin, Adem Deligönül, Erdem Çubukçu, Türkkan Evrensel. Predicting the Unpredictable: Prognostic Role of Systemic Inflammatory Indices and Tumor Biology of Neoadjuvant Chemotherapy Response in Gastric and Gastroesophageal Junction Cancer—Insights from a Systematic Review and Real-World Experience. Journal of Clinical Medicine 2026; 15(4): 1484 doi: 10.3390/jcm15041484
|
| 7 |
H. Wang, L. Mendez, G. Morton, A. Loblaw, H.T. Chung, P. Cheung, A. Mesci, V. Escueta, T.N. Petchiny, X. Huang, S.D. White, M. Downes, D. Vesprini, S.K. Liu. Brachytherapy for high grade prostate cancer induces distinct changes in circulating CD4 and CD8 T cells – Implications for systemic control. Radiotherapy and Oncology 2024; 191: 110077 doi: 10.1016/j.radonc.2023.110077
|
| 8 |
Maodong Leng, Huiqin Jiang, Sitong Zhang, Yixi Bao. Green Synthesis of Gold Nanoparticles from Polygahatous Polysaccharides and Their Anticancer Effect on Hepatic Carcinoma through Immunoregulation. ACS Omega 2024; 9(19): 21144 doi: 10.1021/acsomega.4c01025
|
| 9 |
Jun Xu, Shengnan Hu, Qiuli Chen, Lilu Shu, Peter Wang, Jianjiang Wang. Integrated bioinformatics analysis of noncoding RNAs with tumor immune microenvironment in gastric cancer. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-41444-3
|
| 10 |
Merve Çulha, Fabio S. Lira, Jose C. Rosa-Neto. Molecular mechanism of aerobic exercise in miRNAs and the anti-tumoral effects. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1595982
|
| 11 |
Beatriz I. Fernandez-Gil, Paula Schiapparelli, Juan P. Navarro-Garcia de Llano, Andrea Otamendi-Lopez, Maria Jose Ulloa-Navas, Loizos Michaelides, Carla A. Vazquez-Ramos, Steven M. Herchko, Melissa E. Murray, Yesesri Cherukuri, Yan W. Asmann, Daniel M. Trifiletti, Alfredo Quiñones-Hinojosa. Effects of PreOperative radiotherapy in a preclinical glioblastoma model: a paradigm-shift approach. Journal of Neuro-Oncology 2024; 169(3): 633 doi: 10.1007/s11060-024-04765-5
|